Cresilon Signs International Distribution Agreement for VETIGEL with Covetrus
Cresilon Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced it has entered into a distribution agreement for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons in the U.K. and throughout Europe through Veterinary Instrumentation (Vi), a leading supplier of professional products to support veterinarians in maintaining animal welfare during surgery.